Roland R. Griffiths

Clinical Psychology · 2008–2020

A researcher in the Science corpus: 7 papers; trusts 10 researchers and is trusted by 16 researchers here, as inferred from the citation graph.

Subfields

• Clinical Psychology — 45 citations into it; #921 of 8,024 by trust here, #1,243 by citations
• Social Psychology — 20 citations into it; #10,185 of 15,694 by trust here, #7,393 by citations
• Cellular and Molecular Neuroscience — 14 citations into it; #838 of 2,998 by trust here, #1,827 by citations
• Pharmacology — 14 citations into it; #558 of 1,112 by trust here, #349 by citations
• Applied Psychology — 9 citations into it
• Health — 9 citations into it; #1,345 of 2,035 by trust here, #811 by citations
• Toxicology — 9 citations into it; #44 of 76 by trust here, #53 by citations
• Biological Psychiatry — 6 citations into it

Whom Roland R. Griffiths trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Piedmont
2. Andrew F. Hayes
3. U. McCann
4. M. Scheier
5. R. Jesse
6. W. A. Richards
7. Matthew W. Johnson
8. R. McCrae
9. Franz X. Vollenweider
10. Robin L. Carhart-Harris

Who trusts Roland R. Griffiths overall

1. David E. Nichols
2. Robin L. Carhart-Harris
3. Matthew W. Johnson
4. J. Phelps
5. Katherine A. MacLean
6. M. Bogenschutz
7. David J. Nutt
8. R. Watts
9. Leor Roseman
10. David B. Yaden

Papers from Roland R. Griffiths's perspective

Ordered by how strongly the researchers Roland R. Griffiths trusts endorse each paper. Same corpus, a different order for every researcher.

1. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
2. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
3. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach
4. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
5. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. (Health Psychology)
6. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (Frontiers in Human Neuroscience)
7. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)
8. Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (Journal of Nervous and Mental Disease)
9. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (Psychopharmacology)
10. Religious Coping Methods as Predictors of Psychological, Physical and Spiritual Outcomes among Medically Ill Elderly Patients: A Two-year Longitudinal Study (Journal of Health Psychology)

Their papers

• Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (2011) — 818 citations
• Caffeinated Energy Drinks -- A Growing Problem (2008) — 1,035 citations
• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020) — 1,086 citations
• Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016) — 1,850 citations
• Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (2014) — 848 citations
• Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness (2011) — 795 citations
• Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008) — 812 citations